iSpecimen Inc. (ISPC)
$1.02-5.56%Close
SELLCRISIS · day 38
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $141,639
- Beta
- 1.65
- P/E (TTM)
- -0.02
- Short % float
- 117.09%
- Days to cover
- 1.0
- SI change
- -27.1%
- 1W
- -7.27%
- 1M
- -23.31%
- vs SPY 1W
- -7.13%
- vs SPY 1M
- -25.81%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 1
- VALUE
- 15
- GROWTH
- 16
- GARP
- 3
- TYPE
- Balanced
Composite of Value · Growth · GARP
ROIC-
REV YoY-
ROE-
EPS YoY-
ROA-154.5%
GROSS-151
OP-2020
NET-2449
[VALUATION]
P/E TTM-0.02
P/E FWD-
SECTOR PE20.48
INDUSTRY PE32.29
P/B0.82
P/FCF-
EV/EBITDA0.16
EV/EBIT-
PEG-
FCF YIELD-
RISK
INT COV-
D/E13.87
ALTMAN Z-
CURR RATIO0.82
ND/EBITDA-
BETA1.65
Company news
FAQ
- What is LOPJLB’s current signal on ISPC?
- LOPJLB’s latest quantitative signal on iSpecimen Inc. (ISPC) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is ISPC in?
- iSpecimen Inc. (ISPC) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does iSpecimen Inc. (ISPC) do?
- iSpecimen Inc. operates a sophisticated technological platform that effectively bridges the gap between life science researchers and crucial human biological materials. Its proprietary cloud-based system empowers scientists to efficiently locate and access a vast array of biospecimensâsuch as biofluids, tissues, and living cellsâas well as connect with potential study subjects, all sourced …